Video Experimental Relacionado
Updated: Aug 4, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Púrpura trombocitopénica inducida por el sulfisoxazol. Mecanismo inmunológico como causa
JAMA
|June 16, 1978
Resumen
Los medicamentos sulfonamidas, como el sulfisoxazol, pueden causar púrpura trombocitopénica grave en pacientes con brucelosis. Se confirmaron los mecanismos inmunes, incluida la aglutinación plaquetaria, con una potencial reactividad cruzada con otras sulfonamidas.
Área de la Ciencia:
- Farmacología Farmacología.
- Inmunología Inmunología.
- Hematología Hematología.
Sus antecedentes:
- La brucelosis es una infección bacteriana que a menudo se trata con antibióticos.
- Las reacciones adversas graves al medicamento pueden complicar el tratamiento.
- La púrpura trombocitopénica es una afección grave que implica un bajo recuento de plaquetas.
Objetivo del estudio:
- Para investigar la causa de la púrpura trombocitopénica grave durante el tratamiento de la brucelosis.
- Para verificar el mecanismo inmune subyacente a la trombocitopenia inducida por el fármaco.
- Para evaluar la potencial reactividad cruzada con otros fármacos sulfonamidas.
Principales métodos:
- Observación clínica de un paciente con brucelosis tratado con sulfisoxazol, tetraciclina y sulfato de estreptomicina.
- Desafío de provocación con una pequeña dosis de sulfisoxazol para observar la recurrencia de la trombocitopenia.
- Pruebas de laboratorio serológicas para detectar factores de agregación plaquetaria en el suero del paciente.
- Prueba de reactividad cruzada con otros fármacos sulfonamidas.
Principales resultados:
- Un joven agricultor desarrolló púrpura trombocitopénica severa durante el tratamiento de la brucelosis.
- El desafío clínico con sulfisoxazol confirmó su papel en causar trombocitopenia recurrente.
- Las pruebas serológicas revelaron un factor sérico que aglutinaba las plaquetas en presencia de sulfisoxazol.
- Se ha demostrado la reactividad cruzada con otros fármacos sulfonamidas.
Conclusiones:
- El sulfisoxazol puede inducir la púrpura trombocitopénica mediada por el sistema inmunológico.
- La leche contaminada con drogas sulfonamidas es una fuente potencial de estimulación antigénica.
- La reactividad cruzada con otras sulfonamidas es una consideración clínica importante.
Videos de Conceptos Relacionados
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:20Sulfur Assimilation
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...